Don't want ads? Subscribe or login now.

SEC Must Decide On Teva Whistleblower Award, DC Circ. Told

By Rachel Graf · May 1, 2019, 8:47 PM EDT

A purported whistleblower who claims to have alerted the U.S. Securities and Exchange Commission to misconduct by Teva Pharmaceutical Industries Ltd. eight years ago has accused the securities regulator of taking...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Motion

Case Information

Case Title

In re: John Doe

Case Number

19-1095

Court

Appellate - DC Circuit

Nature of Suit

-

Date Filed

April 29, 2019

Recent Articles By Rachel

November 15, 2019
SEC Whistleblower Office Nets $2B Sanctions After Slower '19
October 11, 2019
Congress Looks To Expand Financial Whistleblower Definition
September 23, 2019
Nissan, Ex-CEO Pay SEC $16M To End Compensation Claims
September 19, 2019
CFTC Calls For Whistleblower Tips As Enforcement Evolves
August 01, 2019
5th Circ. Wrong To Nix $65M Stanford Ponzi Deal, Lloyd's Says
July 12, 2019
Signet: Investor Cert. Needs Clarification. Judge: WRONG
July 10, 2019
Signet Investors Win Cert. In Harassment Statements Suit
June 28, 2019
The Biggest Securities Decisions Of 2019: Midyear Report
June 17, 2019
5th Circ. Sinks $65M Stanford Insurance Scam Deal
June 11, 2019
Signet Can't Duck Investor Suit Over Harassment Statements